Livforsakringsbolaget Skandia’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $225K | Hold |
400
| – | – | 0.01% | 308 |
|
|
2025
Q4 | $271K | Hold |
400
| – | – | 0.01% | 293 |
|
|
2025
Q3 | $255K | Hold |
400
| – | – | 0.01% | 321 |
|
|
2025
Q2 | $214K | Hold |
400
| – | – | 0.01% | 368 |
|
|
2025
Q1 | $168K | Hold |
400
| – | – | 0.01% | 422 |
|
|
2024
Q4 | $165K | Sell |
400
-100
| -20% | -$43.9K | 0.01% | 425 |
|
|
2024
Q3 | $253K | Buy |
500
+400
| +400% | +$194K | 0.01% | 375 |
|
|
2024
Q2 | $48.7K | Hold |
100
| – | – | ﹤0.01% | 387 |
|
|
2024
Q1 | $54K | Hold |
100
| – | – | ﹤0.01% | 391 |
|
|
2023
Q4 | $55.5K | Hold |
100
| – | – | 0.01% | 383 |
|
|
2023
Q3 | $43.7K | Hold |
100
| – | – | ﹤0.01% | 342 |
|
|
2023
Q2 | $50.2K | Hold |
100
| – | – | 0.01% | 328 |
|
|
2023
Q1 | $50K | Hold |
100
| – | – | 0.01% | 333 |
|
|
2022
Q4 | $40.8K | Hold |
100
| – | – | ﹤0.01% | 363 |
|
|
2022
Q3 | $33K | Sell |
100
-200
| -67% | -$73.5K | ﹤0.01% | 381 |
|
|
2022
Q2 | $105K | Sell |
300
-200
| -40% | -$81.6K | 0.01% | 450 |
|
|
2022
Q1 | $274K | Hold |
500
| – | – | 0.02% | 396 |
|
|
2021
Q4 | $329K | Sell |
500
-400
| -44% | -$251K | 0.02% | 367 |
|
|
2021
Q3 | $560K | Sell |
900
-100
| -10% | -$67.2K | 0.04% | 313 |
|
|
2021
Q2 | $632K | Sell |
1,000
-200
| -17% | -$110K | 0.04% | 310 |
|
|
2021
Q1 | $587K | Hold |
1,200
| – | – | 0.04% | 290 |
|
|
2020
Q4 | $600K | Buy |
1,200
+300
| +33% | +$134K | 0.05% | 274 |
|
|
2020
Q3 | $354K | Hold |
900
| – | – | 0.04% | 292 |
|
|
2020
Q2 | $297K | Hold |
900
| – | – | 0.03% | 313 |
|
|
2020
Q1 | $218K | Buy |
900
+300
| +50% | +$78.3K | 0.03% | 324 |
|
|
2019
Q4 | $157K | Sell |
600
-500
| -45% | -$132K | 0.02% | 398 |
|
|
2019
Q3 | $299K | Hold |
1,100
| – | – | 0.04% | 326 |
|
|
2019
Q2 | $303K | Buy |
1,100
+300
| +38% | +$73.9K | 0.04% | 314 |
|
|
2019
Q1 | $179K | Hold |
800
| – | – | 0.02% | 367 |
|
|
2018
Q4 | $149K | Hold |
800
| – | – | 0.02% | 364 |
|
|
2018
Q3 | $200K | Sell |
800
-900
| -53% | -$218K | 0.02% | 381 |
|
|
2018
Q2 | $370K | Hold |
1,700
| – | – | 0.03% | 356 |
|
|
2018
Q1 | $325K | Buy |
1,700
+400
| +31% | +$73.8K | 0.03% | 379 |
|
|
2017
Q4 | $203K | Sell |
1,300
-400
| -24% | -$63K | 0.02% | 478 |
|
|
2017
Q3 | $264K | Hold |
1,700
| – | – | 0.02% | 449 |
|
|
2017
Q2 | $274K | Hold |
1,700
| – | – | 0.03% | 443 |
|
|
2017
Q1 | $263K | Sell |
1,700
-2,500
| -60% | -$345K | 0.02% | 454 |
|
|
2016
Q4 | $493 | Sell |
4,200
-5,647
| -57% | -$644K | 0.03% | 567 |
|
|
2016
Q3 | $1.79M | Buy |
9,847
+1,647
| +20% | +$174K | 0.09% | 309 |
|
|
2016
Q2 | $761K | Buy |
+8,200
| New | +$704K | 0.03% | 494 |
|
Other funds holding IDXX
VCM
VPM
Livforsakringsbolaget Skandia's IDXX Position: Q1 2026 in Review
Livforsakringsbolaget Skandia held its Idexx Laboratories (IDXX) position steady in Q1 2026 at 400 shares worth $225K. The position accounts for 0.01% of the portfolio, ranked #308.
Livforsakringsbolaget Skandia first reported a position in IDXX in Q2 2016 and has held it in 40 quarters since. The position peaked at $1.79M in Q3 2016. 1,315 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- Livforsakringsbolaget Skandia held 400 shares of Idexx Laboratories worth $225K as of Q1 2026.
- Livforsakringsbolaget Skandia left its Idexx Laboratories share count unchanged in Q1 2026.
- Idexx Laboratories made up 0.01% of Livforsakringsbolaget Skandia's portfolio in Q1 2026, its #308 holding.
- Livforsakringsbolaget Skandia first reported a position in Idexx Laboratories in Q2 2016 and has held it in 40 quarters since.
- Livforsakringsbolaget Skandia's Idexx Laboratories position peaked at $1.79M in Q3 2016.
- 1,315 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on Livforsakringsbolaget Skandia's 13F filing for Q1 2026, filed 5 May 2026.